Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korchak, H. M.
Right arrow Articles by Kilpatrick, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korchak, H. M.
Right arrow Articles by Kilpatrick, L. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 42, 27292-27299, October 16, 1998


Selective Role for beta -Protein Kinase C in Signaling for O-2 Generation but Not Degranulation or Adherence in Differentiated HL60 Cells*

Helen M. KorchakDagger , Michael W. Rossi§, and Laurie E. Kilpatrick

From the Departments of Pediatrics and Biochemistry/Biophysics, University of Pennsylvania School of Medicine, The Joseph Stokes Jr. Research Institute of the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 and § Astra Merck, Wayne, Pennsylvania 19087

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

A role for protein kinase C (PKC) isotypes is implicated in the activation of phagocytic cell functions. An antisense approach was used to selectively deplete beta -PKC, both beta I- and beta II-PKC, but not alpha -PKC, delta -PKC, or zeta -PKC in HL60 cells differentiated to a neutrophil-like phenotype (dHL60 cells). Depletion of beta -PKC in dHL60 cells elicited selective inhibition of Obardot 2 generation triggered by fMet-Leu-Phe, immune complexes, or phorbol myristate acetate, an activator of PKC. In contrast, neither ligand-elicited beta -glucuronidase (azurophil granule) release nor adherence to fibronectin was inhibited by beta -PKC depletion. Ligand-induced phosphorylation of a subset of proteins was reduced in beta -PKC-depleted dHL60 cells. Phosphorylation of p47phox and translocation of p47phox to the membrane are essential for activation of the NADPH oxidase and generation of Obardot 2. beta -PKC depletion had no effect on the level of p47phox in dHL60 cells but did significantly decrease ligand-induced phosphorylation of this protein. Furthermore, translocation of p47phox to the membrane in response to phorbol myristate acetate or fMet-Leu-Phe was reduced in beta -PKC-depleted cells. These results indicate that beta -PKC is essential for signaling for Obardot 2 generation but not cell adherence or azurophil degranulation. Depletion of beta -PKC inhibited ligand-induced phosphorylation of p47phox, translocation of p47phox to the membrane, and activation of Obardot 2 generation.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Protein kinase C (PKC)1 mediates signaling for multiple functions of phagocytic cells, neutrophils, monocytes, macrophages, and differentiated HL60 (dHL60) cells. Ligands such as the chemotactic peptide fMet-Leu-Phe and phagocytic stimuli (immune complexes) trigger responses that include Obardot 2 generation, degranulation, adherence, and actin filament assembly (1-8). These functions are essential for the microbicidal activity of phagocytic cells and are also proinflammatory.

PKC, a phospholipid-dependent family of serine/threonine kinases, acts in multiple signal transduction pathways. The cofactor requirements differ between different classes of PKC isotypes. Classical alpha -, beta -, and gamma -PKC are acidic phospholipid, diglyceride (DG), and Ca2+-dependent; novel forms delta -, epsilon -, theta -, and eta -PKC also require acidic phospholipid and DG, but are Ca2+ independent. The atypical PKC isotypes, zeta - and lambda -PKC, require PS but are DG and Ca2+ independent (9-14). PKC isotypes differ in their tissue distribution and localization within the cell, suggesting that each isotype plays a specific role in signal transduction.

Neutrophils, monocytes/macrophages, and dHL60 cells contain multiple isotypes of PKC, including Ca2+-dependent isotypes alpha -PKC, beta I-PKC, and beta II-PKC, Ca2+-independent DG-dependent isotype, delta -PKC, and atypical PS-dependent, Ca2+/DG-independent zeta -PKC (3, 14-16). PKC has been implicated in the signaling for several different responses of phagocytic cells because PMA triggers Obardot 2 generation and adherence but not the release of azurophil granules (1, 17). The PKC substrates involved in these processes are largely unknown. The cytoskeleton and integrins are involved in cell adherence, and several cytoskeletal proteins, including MARCKS, are PKC substrates (8). Assembly of an active NADPH oxidase for generation of Obardot 2 requires translocation of cytosolic factors p47phox, p67phox, and rac2 to the plasma membrane, where they interact with the integral membrane protein cytochrome b558 (18-25). p47phox is phosphorylated in ligand-activated phagocytic cells. p47phox contains multiple phosphorylation sites, including a number of classical PKC substrate sites (RXXS/TXRX) and is phosphorylated by beta -PKC in vitro (3). In addition, p47phox phosphorylated in vitro by PKC, but not cAMP-activated kinase or mitogen-activated kinase, was active in a cell-free system for activation of the NADPH oxidase (4-7). However, in vitro activity does not necessarily predict a role for a particular PKC isotype in the intact cell, where access to both substrate and cofactors is critical in controlling signaling specificity. Specific functions for each PKC isotype remain to be established.

In the present study, an antisense strategy was used to probe a role for a specific PKC isotype in signaling for the ligand-activated responses of Obardot 2 generation and cell adherence in dHL60 cells. beta -PKC was selectively depleted by an antisense strategy in dHL60 cells. Selective depletion of beta -PKC in dHL60 cells decreased Obardot 2 generation but not degranulation or adherence. Depletion of beta -PKC reduced ligand-induced phosphorylation of a subset of proteins including p47phox and reduced translocation of p47phox to the membrane, concordant with a selective role for beta -PKC in signaling for assembly of an active NADPH oxidase.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Reagents-- Cytochalasin B, cytochrome c, phenolphthalein glucuronidate, protease inhibitors (leupeptin and aprotinin), BSA, PMA, fMet-Leu-Phe, and PMSF were purchased from Sigma. PMA was stored as a concentrated stock solution in Me2SO and diluted with Krebs-Ringer buffer before use. fMet-Leu-Phe was stored as a stock solution in ethanol and diluted in buffer prior to use. BSA and anti-BSA IgG (Cappel, Durham, NC) were used to form an immune complex by the method of Ward and Zvaifler (26).

Anti-peptide polyclonal antibodies to alpha -PKC, beta I-PKC, beta II-PKC, gamma -PKC, delta -PKC, epsilon -PKC, theta -PKC, and eta -PKC and peroxidase-conjugated goat anti-rabbit IgG were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Mouse monoclonal antibodies to delta -PKC and zeta -PKC and a rabbit polyclonal antibody to p47phox were purchased from Transduction Laboratories (Lexington, KY). A mouse monoclonal antibody to p47phox and a rabbit polyclonal antibody to gp91phox were gifts from J. Curnutte (Genentech). Protein A-agarose was obtained from Life Technologies, Inc.

HL60 Cell Culture-- Human promyelocytic HL60 leukemic cells were obtained from the American Type Culture Collection (Rockville, MD). The cells were grown in suspension culture in RPMI 1640 medium supplemented with 2 mM L-glutamine, 1% nonessential amino acids, 1% minimal essential medium vitamin solution, 0.1% gentamicin, and 10% heat-inactivated fetal bovine serum. The cell cultures were maintained at 37 °C in a 5% CO2 humidified atmosphere.

Oligonucleotide Synthesis and Sequences-- An antisense oligonucleotide was designed against the translation start site of human beta -PKC using the commercial primer analysis software Oligo (National Biosciences). Since beta I-PKC and beta II-PKC differ only in the 3' terminus, this oligonucleotide should target both forms of beta -PKC. A 19-mer sequence was chosen, which was without significant self-complimentarity and did not dimerize. The chosen sequence was also optimized for maximal Tm to promote high affinity binding to mRNA; a Tm of 70.0 °C was calculated at 150 mM salt and 37 °C. The 19-mer oligonucleotides had the following sequences: beta -PKC antisense (beta AS), 5'-AGC CGG GTC AGC CAT CTT G-3', beta -PKC sense (beta SS), 5'-C AAG ATG GCT GAC CCG GCT-3'. The unique nature of these sequences was confirmed by searching the GenBank data base. Antisense, sense, and scrambled control oligonucleotides were synthesized by the PENN Nucleic Acid Facility as the phosphorothioate derivatives and purified by high pressure liquid chromatography. In all oligonucleotides, the internucleoside linkages were completely phosphorothioate-modified.

Treatment of Cells with Oligonucleotides-- Delivery of the oligonucleotides was enhanced equally with cationic lipids DMRIE-C (1,2-dimyristoyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/cholesterol (1:1 (M/M))) and Lipofectin (Life Technologies, Inc.); however, DMRIE-C was chosen since this lipid lacks dioctanoyl phosphatidylethanolamine, which can be toxic to phagocytic cells, and allowed optimal retention of cell functions (27). HL60 cells were cultured in the presence of 1.3% Me2SO for 4 days to initiate differentiation before treatment with the oligonucleotide. On day 4, the cells were washed and resuspended in Opti-MEM I reduced serum medium (Life Technologies, Inc.) at a cell concentration of 25 × 106 cells/well. Oligonucleotides beta AS, beta SS, or beta MS (a scrambled AS oligonucleotide) were suspended in Opti-MEM at a final concentration of 100-1000 nM and mixed with the cationic lipid DMRIE-C (2.5 µg/ml). The cationic lipid/oligonucleotide mixture was added to the cells and incubated at 37 °C for 4 h. An equal volume of RPMI 1640 medium containing 20% heat-inactivated fetal bovine serum plus Me2SO (1.3% final concentration) was then added, and the cells cultured for 20 h. On day 5, the cells were washed and resuspended in fresh Opti-MEM and treated again with the cationic lipid/oligonucleotide mixture. Following 4 h of incubation, an equal volume of RPMI 1640 medium containing 20% heat-inactivated fetal bovine serum plus Me2SO (1.3% final concentration) was then added, and the cells were cultured for an additional 24 h. The cells were harvested and suspended in Krebs-Ringer phosphate-buffered saline, pH 7.4, containing 1.2 mM Mg2+ and 1.3 mM Ca2+.

Western Blots-- Differentiated HL60 cell lysates (1 × 106 cells/sample) were prepared by heating the cells at 95 °C for 5 min in 2 × SDS-PAGE sample buffer. The samples were briefly sonicated (12 s) to reduce viscosity. The dHL60 cell lysates were run on a 4-16% gradient SDS-PAGE, transferred to PVDF membrane, and blocked for 1 h at room temperature with Tris-buffered saline, pH 7.5, containing 0.1% Tween 20 and 1% BSA, 3% casein. To identify the different PKC isotypes, the membrane was incubated with a panel of PKC antibodies, followed by incubation with peroxidase-conjugated goat anti-rabbit IgG. Immunoreactive bands were visualized by Pierce SuperSignal ULTRA chemiluminescence substrate. The software SigmaProscan (Jandel/SPSS) was used for densitometric analysis; rhPKC isotypes (Pan Vera) were used as standards for quantitation.

Protein Kinase C Assay-- Cytosol fractions were prepared by sonicating dHL60 cells in 50 mM Tris-HCl, pH 7.5, containing 2 mM PMSF, 33 µM leupeptin, 35 µM antipain, 24 µg/ml chymostatin, 35 µM pepstatin, and 0.48 TIU/ml aprotinin, 10 mM EGTA, and 50 mM mercaptoethanol, as described previously (2), and by centrifuging for 20 min at 115,000 × g at 4 °C. PKC activity of cytosol fractions was assayed in the presence of Ca2+, PS, and DG by measuring the incorporation of 32P into histone type IIIS or into PKC substrate peptide [Ser25]PKC(19-31) (2). The net Ca2+-dependent activity was obtained by subtraction of the Ca2+-independent, PS/DG activity from the Ca2+/PS/DG-dependent activity.

Superoxide Anion Generation-- The generation of superoxide anion (Obardot 2) by dHL60 cells was measured as superoxide dismutase-inhibitable cytochrome c reduction by either a continuous recording method (28) or end point analysis. Cells were activated by 1 µM fMet-Leu-Phe in the presence of 5 µg/ml cytochalasin B, or by 1 µg/ml PMA, or 300 µg/ml BSA/anti-BSA immune complex in the absence of cytochalasin B.

Degranulation-- The release of the azurophil granule-associated enzyme beta -glucuronidase triggered by fMet-Leu-Phe from dHL60 cells was measured in the presence of 5 µg/ml cytochalasin B to allow extracellular release of granule contents. Degranulation triggered by insoluble immune complex, BSA/anti-BSA, was measured in the absence of cytochalasin B. dHL60 cells (5 × 106 cells/ml) were incubated for 5 min at 37 °C with buffer, fMet-Leu-Phe (1 µM) or BSA/anti-BSA (300 µg/ml). beta -Glucuronidase was determined by a microplate assay using phenolphthalein glucuronidate as substrate (29, 30). Total enzyme activities were determined simultaneously in reaction mixtures containing the detergent Triton X-100 (0.2%) and using phenolphthalein to calibrate the nmoles of cleaved substrate.

Adherence-- Adherence of dHL60 cells to fibronectin-coated plates was determined by a colorimetric assay according to the method of Aumailley et al. (31). 96-well microtiter plates were coated with fibronectin as described by Nathan et al. (32). dHL60 cells (4 × 105 cells/well) were incubated for 30 min at 37 °C with either buffer, fMet-Leu-Phe (1 µM) or PMA (1 µg/ml). Nonadherent cells were removed by washing with Krebs-Ringer phosphate-buffered saline buffer, and the adherent cells were fixed with 70% ethanol. The bound cells were stained with crystal violet (0.1% in dH2O). The plates were washed extensively to remove excess stain, and the cells were solubilized with 1% Nonidet P-40 in dH2O. Optical density was read at 550 nm.

Protein Phosphorylation in Activated dHL60 Cells-- dHL60 cells (50 × 106 cells/ml) were incubated for 60 min at 37 °C with 32P-Pi (250 µCi of [32P]orthophosphoric acid/ml). The 32P-labeled cells were stimulated with either buffer alone or fMet-Leu-Phe (1 µM) for 1 min in the presence of 5 µg/ml cytochalasin B. The reaction was stopped by placing the samples on ice. Cell lysates were prepared and run on 4-12% gradient SDS-PAGE. The gel was dried and subjected to autoradiography.

Immunoprecipitation of p47phox-- dHL60 cells (10 × 106 cells/ml) were incubated for 60 min at 37 °C with 32P-Pi (250 µCi of [32P]orthophosphoric acid/ml). The 32P-labeled cells were stimulated with either buffer alone, PMA (1 µg/ml) or fMet-Leu-Phe (1 µM), for 10 min. The reaction was stopped by the addition of cold immunoprecipitation (IP) buffer. IP buffer consisted of 10 mM HEPES (pH 7.4) containing 150 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, 2 mM PMSF, 0.2% Nonidet P-40, 0.027 TIU/ml aprotinin, 2 µg/ml leupeptin, and 5 mg/ml BSA. The samples were then vortexed for 20 min to solubilize the membrane fraction, and the supernatant was collected after microfuging for 5 min. A rabbit polyclonal antibody to p47phox was added and incubated overnight at 4 °C. Protein A-agarose was added and incubated for 1 h at 4 °C with shaking. The reaction tubes were then microfuged for 30 s, and the supernatants were discarded. The protein A-agarose pellet was washed four times with IP buffer, and the sample was eluted by incubation for 20 min at 65 °C in 2 × SDS-PAGE sample buffer.

Preparation of Particulate Fractions from fMet-Leu-Phe-stimulated dHL60 Cells and Translocation of p47phox and PKC Isotypes to Cell Membranes-- dHL60 cells (2.5 × 107 cells/ml) were incubated at 37 °C in the presence of buffer, 1 µM fMet-Leu-Phe (1 min) or 1 µg/ml PMA (5 min). At the end of the incubation period, the cell suspension was transferred to an ice bath. The suspension was then centrifuged for 10 min at 300 × g, and the cell pellet was resuspended in buffer containing 131 mM NaCl, 1 mM EGTA, 100 mM potassium phosphate buffer, pH 7.0, 2 mM PMSF, 20 µg/ml leupeptin, 20 µg/ml aprotinin, and 20 µg/ml pepstatin (buffer A). (24). The cells were disrupted using three 5-s bursts of a microprobe sonicator at low power at 4 °C and centrifuged at low speed (500 × g, 5 min) to remove unbroken cells and nuclei. The supernatant was layered over a 15% sucrose cushion made up in buffer A and centrifuged at 4 °C for 20 min at 115,000 × g. The supernatant (cytosol) was mixed 4:1 with 4 × SDS sample buffer. The pellet was solubilized in hot Laemmli buffer; pellet (10 × 106 cell equivalents/lane) and cytosol (3 × 106 cell equivalents/lane) were run on 4-12% SDS-PAGE and probed by Western blotting.

Statistical Analysis-- Results are expressed as mean ± S.E. (n). Data were analyzed by Student's one-tailed t test for paired samples.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Depletion of beta -PKC Isotypes by Antisense Treatment-- To deplete beta -PKC, dHL60 cells were first treated with 1.3% Me2SO for 4 days to initiate differentiation, followed by two treatments with beta -PKC antisense oligonucleotide (beta AS) and the cationic lipid DMRIE-C (2.5 µg/ml) at 24-h intervals (see "Materials and Methods"). Preliminary experiments demonstrated that cationic lipids were essential to enhance the potency of the oligonucleotides (33, 34). Phosphorothioate oligonucleotides were synthesized since these have a greater intracellular half-life than the native oligonucleotides. Since the half-life of PKC is long, reported to vary from 6.7 h to over 24 h, prolonged treatment with beta AS was used (35). The cells were treated twice with the beta AS/DMRIE-C mixture to prolong the exposure to beta AS and to achieve decreased protein expression of beta -PKC (35); a single treatment with beta AS/DMRIE-C was not effective. The effect of antisense treatment on dHL60 cells following differentiation was examined over a concentration range of 0-1000 nM beta AS (Fig. 1). Treatment with beta AS resulted in decreased expression of beta -PKC (Fig. 1). Depletion of beta -PKC followed a bell-shaped concentration response curve; maximal depletion of beta -PKC immunoreactivity occurred at 250 and 500 nM beta AS (Fig. 1). For this experiment, beta -PKC was reduced to 23 and 31% of control levels by 250 and 500 nM beta AS, respectively. At higher concentrations of beta AS oligonucleotide, there was increased beta -PKC expression. Attempts to enhance the depletion of beta -PKC by more prolonged incubation or by increases in cationic lipid levels were not successful due to a loss of cell viability.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of beta -PKC antisense oligonucleotide concentration on depletion of beta -PKC in neutrophilic HL60 cells. dHL60 cells were treated with 0, 100, 250, 500, or 1000 nM beta -PKC AS oligonucleotide (beta AS) for 48 h (see "Materials and Methods"). Cell lysates were prepared by adding Laemmli buffer, and the samples were subjected to 4-16% SDS-PAGE followed by Western blotting (representative experiment of three). beta -PKC is indicated by an arrow on the right.

Selective Depletion of beta -PKC and Not alpha -PKC, delta -PKC, or zeta -PKC-- dHL60 contained numerous PKC isotypes, alpha -PKC, beta I-PKC, beta II-PKC, delta -PKC, and zeta -PKC, in agreement with other workers (Fig. 2A) (15). The predominant isotypes were alpha -, beta II-, and delta -PKC, whereas beta I-PKC and zeta -PKC were present at lower levels (Fig. 2A). No evidence for epsilon -PKC (Fig. 2A), gamma -PKC, eta -PKC, or theta -PKC (results not shown) was found in dHL60 cells. dHL60 cells were treated for 48 h with 300 nM beta -PKC antisense (beta AS) and beta -PKC missense oligonucleotide (beta MS) in the presence of DMRIE-C (2.5 µg/ml). Selectivity of depletion of beta -PKC was assessed by probing the blot with antibodies to alpha -PKC, beta I-PKC, beta II-PKC, delta -PKC, and zeta -PKC. Both beta -PKC isotypes, beta I-PKC and beta II-PKC, were effectively depleted by beta AS treatment but not by beta MS treatment (Fig. 2B) or in sense oligonucleotide-treated cells (results not shown). beta I-PKC was reduced to 45.6 ± 5.3% (n = 10) of control (beta MS) levels, and beta II-PKC was reduced to 60.8 ± 4.4% (n = 10) of control levels. In contrast, a concentration of beta AS, which was effective in depleting beta -PKC, had no effect on the expression of other PKC isotypes including alpha -PKC, delta -PKC, and zeta -PKC (Fig. 2B). Calcium/PS/DG-dependent histone IIIs phosphorylating activity was 21.6 pmol/107 cell equivalents/min in cytosol from control beta MS-treated cells; calcium/PS/DG-dependent phosphorylating activity in beta -PKC-depleted cells was reduced to 73.6 ± 1.7% (n = 3, p < 0.001) of control activity. This finding demonstrates that beta AS depleted, but did not abolish, calcium-dependent PKC activity. Thus, treatment with the beta -PKC antisense oligonucleotide selectively depleted dHL60 cells of beta -PKC but not calcium-dependent alpha -PKC or calcium-independent delta -PKC and zeta -PKC.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 2.   An antisense beta -PKC oligonucleotide selectively decreases beta -PKC expression. A, PKC isotypes in neutrophilic HL60 cells. Cell lysates were prepared from dHL60 cells, run on a 4-15% gradient SDS-PAGE, and blotted to PVDF membrane. Western blotting was performed using polyclonal antibodies to alpha -, beta I-, beta II-, delta -, and epsilon -PKC and a monoclonal antibody to zeta -PKC. B, selective depletion of beta -PKC by a beta -PKC antisense oligonucleotide. dHL60 cells were treated with 300 nM beta -PKC antisense oligonucleotide (beta AS) or beta -PKC missense oligonucleotide (beta MS) in the presence of 2.5 µg/ml DMRIE-C (see "Materials and Methods"). Cell lysates were prepared by adding Laemmli buffer, and the samples were subjected to 4-16% SDS-PAGE followed by Western blotting (representative experiment of four). Molecular weight markers are indicated on the left, and PKC is indicated by an arrow on the right.

Effect of beta -PKC Depletion on Superoxide Anion Generation by dHL60 Cells-- Activation of dHL60 cells by a variety of stimuli elicits the assembly of an active NADPH oxidase enzyme complex, which generates superoxide anion (Obardot 2). Previous studies suggested that beta -PKC may play an important role in the activation of the NADPH oxidase (3, 20). Therefore, the effect of beta -PKC depletion on Obardot 2 generation triggered by different ligands was evaluated. The PKC activator PMA (1 µg/ml) triggered continuous generation of Obardot 2 by dHL60 cells following a lag period of approximately 1-3 min (Fig. 3A). The mean lag period for control beta MS-treated cells was 205 ± 55 s (n = 5); the lag period was significantly increased to 222 ± 43% (n = 5) of control (p < 0.05) in beta AS-treated cells. Thus, depletion of beta -PKC delayed the onset of Obardot 2 generation in PMA-activated cells. Control beta MS-treated cells generated 33.5 ± 6.2 nmol (n = 5) Obardot 2/106 cells/15 min (Fig. 3C). Treatment of cells with DMRIE-C/oligonucleotide was not toxic to the cells since the rate of Obardot 2 generation in the absence of DMRIE-C/oligonucleotide was 39.14 ± 5.7 (n = 4) nmol Obardot 2/106 cells/15 min as compared with the rate of 33.50 ± 6.2 (n = 5) nmol Obardot 2/106 cells/15 min in DMRIE-C/beta MS-treated cells, a difference that is not significant. When dHL60 cells were treated with beta AS (Fig. 2B), PMA-elicited Obardot 2 production was significantly decreased to a level of 25.1 ± 6.2 (n = 5) nmol Obardot 2/106 cells/15 min (p < 0.01), a level that was 71.6 ± 7.8% of control (p < 0.02) (Fig. 3C). In addition, the Vmax of PMA-induced Obardot 2 generation, defined as the maximal rate of Obardot 2 generation, was reduced in cells depleted of beta -PKC. Calculation of the Vmax demonstrated that in beta MS-treated cells activated by 1 µg/ml PMA, the Vmax was 2.51 ± 0.80 (n = 5) nmol/min/106 cells; the Vmax of beta -PKC-depleted cells was significantly reduced to 2.04 ± 0.70 nmol/min/106 cells (n = 5), which was 75.8 ± 7.8% of control beta MS-treated cells (p < 0.04).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Depletion of beta -PKC inhibits Obardot 2 generation by dHL60 cells. Characterization of Obardot 2 generation by dHL60 cells depleted of beta -PKC. Obardot 2 generation measured as the superoxide dismutase-inhibitable reduction of cytochrome c (see "Materials and Methods") in missense (beta MS) and antisense (beta AS) pretreated dHL60 cells. A, time course of Obardot 2 generation triggered by 1 µg/ml PMA. B, time course of Obardot 2 generation triggered by 1 µM fMet-Leu-Phe plus 5 µg/ml cytochalasin B. C, Obardot 2 generation triggered by 1 µg/ml PMA, 1 µM fMet-Leu-Phe plus 5 µg/ml cytochalasin B, and 300 µg/ml BSA/anti-BSA immune complex. Data shown are representative of five experiments (PMA), eight experiments (fMLP), and three experiments (BSA/anti-BSA) and are expressed as nmol Obardot 2/106 cells/15 min.

The chemotactic peptide, fMet-Leu-Phe (1 µM), triggers Obardot 2 generation by dHL60 cells in the presence of cytochalasin B (Fig. 3B). The onset of Obardot 2 generation was rapid but ceased after 3-4 min. (Fig. 3B). Control (beta MS-treated) cells activated by 1 µM fMet-Leu-Phe generated 16.88 ± 2.6 nmol/106 cells/15 min (n = 8) (Fig. 3C). Obardot 2 generation was significantly decreased in beta -PKC-depleted (beta AS-treated) cells to 4.83 ± 2.1 nmol/106 cells/15 min (n = 8) (p < 0.001), a level that was 28.5% of control values (p < 0.01) (Fig. 3C). The kinetics of inhibition Obardot 2 generation following beta -PKC depletion were examined in fMet-Leu-Phe-activated cells. The lag time of reaction was approximately 10-15 s. after addition of f-Met-Leu-Phe, and was not significantly altered by depletion of beta -PKC. However, the Vmax of fMet-Leu-Phe-induced Obardot 2 generation was significantly decreased in beta -PKC-depleted cells as compared with controls. The Vmax of Obardot 2 generation decreased significantly from a rate of 3.36 ± 0.57 nmol/min/106 cells (n = 8) in control beta MS-treated cells to a Vmax of 1.45 ± 0.28 nmol/min/106 cells (p < 0.002, n = 8) in beta -PKC-depleted cells. Ligands such as immune complexes, in addition to fMet-Leu-Phe, also trigger Obardot 2 generation by dHL60 cells. beta AS treatment decreased Obardot 2 generation in response to immune complex from 2.02 ± 0.14 nmol/106 cells/15 min (n = 3) in beta MS-treated cells to 1.04 ± 0.22 nmol/106 cells/15 min (n = 3) in beta AS-treated cells (Fig. 3C) and decreased the Vmax from 0.68 ± 0.04 nmol/min/106 cells (n = 3) to 0.35 ± 0.07 nmol/min/106 cells (n = 3) (p < 0.01).

Thus, depletion of beta -PKC in dHL60 cells results in inhibition of the rate of Obardot 2 generation in response to a number of different ligands. The extent of inhibition of Obardot 2 generation by beta -PKC depletion was stimulus dependent; the greatest inhibition of Obardot 2 generation by beta -PKC depletion was observed in cells activated by fMet-Leu-Phe.

Depletion of beta -PKC Isotypes Does Not Inhibit fMet-Leu-Phe-elicited Degranulation by dHL60 Cells-- Activation of dHL60 cells with ligands such as fMet-Leu-Phe triggers release of beta -glucuronidase, an azurophil granule marker, simultaneously with the generation of Obardot 2. The effect of depletion of beta -PKC on the extracellular release of beta -glucuronidase was monitored in dHL60 cells following stimulation with 1 µM fMet-Leu-Phe. Treatment of dHL60 cells with beta AS plus DMRIE-C, at a concentration that significantly depleted levels of beta -PKC and inhibited Obardot 2 production in response to fMet-Leu-Phe, had no significant effect on degranulation (Fig. 4); 10.5 ± 2.7% (n = 4) of total beta -glucuronidase was released in response to fMet-Leu-Phe in control (beta MS-treated) cells, whereas 12.2 ± 2.5% (n = 4) of total beta -glucuronidase was released from beta -PKC-depleted cells. Similarly, degranulation triggered by BSA/anti-BSA in the absence of cytochalasin B was not affected by depletion of beta -PKC; 7.5 ± 0.2% (n = 4) of total beta -glucuronidase was released in response to BSA/anti-BSA in control (beta MS-treated) cells, whereas 8.3 ± 0.6% (n = 4) of total beta -glucuronidase was released from beta -PKC-depleted cells. Furthermore, total cell content of beta -glucuronidase, a marker for HL60 cell differentiation, was not altered in beta -PKC-depleted cells (Fig. 4). Therefore, depletion of beta -PKC with a beta -PKC antisense oligonucleotide selectively inhibits ligand-elicited Obardot 2 generation but not beta -glucuronidase release.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Release of beta -glucuronidase by dHL60 cells depleted of beta -PKC. The effect of depletion of beta -PKC on the release of beta -glucuronidase was monitored in missense (beta MS) and antisense (beta AS) pretreated dHL60 cells (see "Materials and Methods"). dHL60 cells were preincubated for 5 min at 37 °C before addition of 1 µM fMet-Leu-Phe; cytochalasin B was present at 5 µg/ml in all tubes. Results are expressed as nmol of glucuronate released/106 cells, mean ± S.E. (n = 4).

Effect of beta PKC Depletion on Adherence of dHL60 Cells to Fibronectin-- A role for PKC in integrin-mediated adherence to fibronectin has been suggested since phorbol esters activate adherence mechanisms in phagocytic cells (7, 36). To ascertain whether beta -PKC plays a role in integrin-mediated adherence in dHL60 cells, the effect of beta -PKC depletion on basal and stimulated adherence to fibronectin was examined in dHL60 cells. Activation of control (beta MS-treated) cells by PMA (1 µg/ml) or fMet-Leu-Phe (1 µM) triggered increased cell adherence to fibronectin-coated wells (Fig. 5). PMA produced the greatest increase in adherence, to 242.1 ± 64.0% (n = 4) of resting levels in control (beta MS-treated) cells, whereas in beta -PKC-depleted cells, a similar level of PMA-induced adherence, 246.8 ± 40.0% (n = 4) of resting levels, was observed. fMet-Leu-Phe (1 µM) triggered increased adherence to 175.1 ± 41.5% (n = 3) of resting levels in control (beta MS-treated) cells, whereas in beta -PKC-depleted cells, a similar level of fMet-Leu-Phe-induced adherence, 214.38 ± 62.5% (n = 4) of resting levels, was observed. As shown in Fig. 5, beta AS treatment under conditions that significantly altered fMet-Leu-Phe and PMA-induced Obardot 2 production had no significant effect on cell adherence to fibronectin in unstimulated or stimulated cells. Thus, depletion of beta -PKC in dHL60 cells elicits selective inhibition of Obardot 2 generation but not beta -glucuronidase release or adherence to fibronectin.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of depletion of beta -PKC on adherence of dHL60 cells to fibronectin. Adherence of dHL60 cells to fibronectin-coated plates was determined in missense (beta MS) and antisense (beta AS) pretreated dHL60 cells (see "Materials and Methods"). dHL60 cells were preincubated for 5 min at 37 °C before addition of buffer, 1 µg/ml PMA or 1 µM fMet-Leu-Phe, followed by incubation for 30 min at 37 °C. Data are representative of six experiments for PMA and three experiments for fMet-Leu-Phe.

Effect of beta -PKC Depletion on Protein Phosphorylation Triggered by 1 µM fMet-Leu-Phe-- beta AS- and beta MS-treated dHL60 cells were labeled with 32P inorganic phosphate for 1 h at 37 °C and treated with buffer or fMet-Leu-Phe. Cell lysates were prepared, the phosphorylated proteins were separated on SDS-PAGE, and the gels were subjected to autoradiography. Activation of the cells for 1 min with 1 µM fMet-Leu-Phe triggered phosphorylation of multiple proteins, including 18-, 24-, 38-, 43-, 47-, 54-, 68-, and 80-kDa proteins (Fig. 6A). Phosphorylation of prominent 14-, 97-, and 105-kDa bands was not significantly altered in fMet-Leu-Phe-activated cells (Fig. 6A). Densitometry of the autoradiograph demonstrated that treatment of cells with antisense to beta -PKC reduced the fMet-Leu-Phe-induced phosphorylation of the 18-, 38-, 43-, 47-, 54-, and 68-kDa proteins (Fig. 6B); the 47-kDa band is a candidate for p47phox. In contrast, phosphorylation of a band at 105 kDa was enhanced in beta -PKC-depleted cells. The effect of beta -PKC depletion on fMet-Leu-Phe-induced protein phosphorylation was selective, since treatment with beta AS had no significant effect on the fMet-Leu-Phe-induced phosphorylation of the 24- or 80-kDa bands. These results suggest that depletion of beta -PKC inhibits fMet-Leu-Phe-induced phosphorylation of a discrete number of proteins including a 47-kDa band, which is a candidate for p47phox, an important component of the NADPH oxidase.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of depletion of beta -PKC on protein phosphorylation in activated dHL60 cells. dHL60 cells were treated with beta -PKC antisense (beta AS) or missense (beta MS) oligonucleotides (see "Materials and Methods") and then labeled with 250 µCi 32Pi/ml for 1 h at 37 °C. Cells were pretreated with 5 µg/ml cytochalasin B for 1 min and then stimulated with buffer (control) or 1 µM fMLP for 1 min. The cells were solubilized in Laemmli buffer and subjected to 4-12% SDS-PAGE followed by autoradiography (representative of three experiments). A, autoradiography of gel. Lane 1, beta AS-pretreated control cells; lane 2, beta MS-pretreated control cells; lane 3, beta AS-pretreated fMLP-stimulated cells; and lane 4, beta MS-pretreated fMLP-stimulated cells. Molecular weight markers are indicated on the left margin, and phosphorylated bands are indicated on the right margin. B, scanning densitometry of the autoradiograph was analyzed by ScanPro and plotted as density versus molecular weight. beta AS-pretreated control cells and beta MS-pretreated control cells are shown in the upper panel, and beta AS-pretreated fMLP-stimulated cells and beta MS-pretreated fMLP-stimulated cells are shown in the lower panel.

Depletion of beta -PKC and Reduced Ligand-initiated Phosphorylation of p47phox-- Phosphorylation of p47phox and its translocation to the membrane-associated cytochrome b558 is essential for assembly of the NADPH oxidase. beta -PKC-depleted dHL60 cells were used to determine whether beta -PKC was essential for phosphorylation of p47phox in cells activated by fMet-Leu-Phe. dHL60 cells were pretreated with beta AS or beta MS and stimulated for 1 min with 1 µM fMet-Leu-Phe; the p47phox was then immunoprecipitated. Western blotting and densitometry analysis demonstrated that control (beta MS) and beta -PKC-depleted (beta AS) dHL60 cells contained equivalent amounts of p47phox immunoreactivity (Fig. 7A). However, phosphorylation of the p47phox band was reduced in the beta AS-treated dHL60 cells as compared with the control (beta MS-treated) cells; 32P counts eluted from the beta AS band were 56% of control levels measured in the beta MS band (Fig. 7B). beta -PKC-depleted cells contained equivalent protein levels of p47phox as compared with control cells. However, fMet-Leu-Phe-induced phosphorylation of p47phox was decreased in the beta -PKC-depleted cells, concordant with a role for beta -PKC in phosphorylation of p47phox in ligand-initiated signaling and in the assembly of an active NADPH oxidase.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of depletion of beta -PKC on phosphorylation of p47phox in dHL60 cells activated by fMet-Leu-Phe. dHL60 cells treated with beta AS or beta MS oligonucleotides were prelabeled with 32P-Pi (300 µCi) for 60 min at 37 °C. fMLP (1 µM) was added (zero time), and the reaction was stopped after 1 min. p47phox was immunoprecipitated from each sample, and the immune complexes were run on 4-12% gradient SDS-PAGE and blotted to PVDF membrane. Representative experiment of two. A, Western blot using anti p47phox. B, autoradiogram of membrane. Molecular weight markers are indicated on the left margin and p47phox on the right margin.

Effect of beta PKC Depletion on p47phox Translocation-- Phosphorylation and translocation of p47phox to the membrane and association of phosphorylated p47phox with cytochrome b558 are essential steps in the assembly of an active NADPH oxidase complex. Activation of dHL60 cells by fMet-Leu-Phe or PMA elicited translocation of p47phox from the cytosol to the membrane fraction (Fig. 8). Depletion of beta -PKC by beta AS treatment was associated with decreased translocation of p47phox from the cytosol to the membrane in both fMet-Leu-Phe- and PMA-activated cells as compared with beta MS-treated controls (Fig. 8). In contrast, the membrane-associated gp91phox subunit of cytochrome b558 was not affected by depletion of beta -PKC (Fig. 8). In resting cells, beta I-PKC and beta II-PKC were predominantly in the cytosol (Fig. 8). Activation of dHL60 cells by 1 µM fMet-Leu-Phe for 1 min elicited translocation of both beta I-PKC and beta II-PKC from the cytosol to the membrane (Fig. 8). Activation of the cells with 1 µg/ml PMA for 5 min triggered an almost total disappearance of beta I-PKC and beta II-PKC from the cytosol and translocation of both isotypes to the membrane (Fig. 8). In the beta -PKC-depleted cells, less beta I and beta II-PKC was associated with the membrane in fMet-Leu-Phe- and PMA-treated cells (Fig. 8). Densitometry demonstrated that in fMet-Leu-Phe-activated cells, 606 ± 121 DU (density units) (n = 5) of beta II-PKC was associated with the membrane in beta -PKC-depleted cells as compared with 999 ± 162 DU (n = 5) in beta MS-treated cells (60.1 ± 9.5% control, p < 0.03). In PMA-activated cells, 1125 ± 162 DU (n = 4) of beta II-PKC was associated with the membrane in beta -PKC-depleted cells as compared with 1483 ± 181 DU (n = 4) in beta MS-treated cells (75.0 ± 3.9% control, p < 0.02). Similarly, membrane-associated beta I-PKC was significantly reduced to 125 ± 17 DU (n = 5) in beta -PKC-depleted cells activated with fMet-Leu-Phe as compared with 481 ± 144 DU (n = 5) in beta MS-treated control cells (39.0 ± 3.7% control, p < 0.01). In PMA-activated cells, membrane-associated beta I-PKC was significantly reduced to 596 ± 113 DU (n = 5) in beta -PKC-depleted cells activated as compared with 991 ± 98 DU (n = 5) in beta MS-treated control cells (58.4 ± 6.7% control, p < 0.01). These results are concordant with a role for beta -PKC-dependent phosphorylation of p47phox in translocation of p47phox to the membrane and assembly of an active NADPH oxidase.


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of depletion of beta -PKC on translocation of cytosolic p47phox and beta -PKC isotypes to cell membranes in resting, fMet-Leu-Phe-, and PMA-activated dHL60 cells. dHL60 cells were treated with beta AS or beta MS oligonucleotides (see "Materials and Methods"). dHL60 cells were treated with buffer, 1 µM fMet-Leu-Phe (1 min) or 1 µg/ml PMA (5 min). Membrane (10 × 106 cell equivalents/lane) and cytosol (3 × 106 cell equivalents/lane) fractions were prepared, run on 4-12% gradient SDS-PAGE, blotted to PVDF membrane, and probed with antibodies to p47phox, beta I-PKC, beta II-PKC, and gp91phox. Representative experiment of five.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

A role for PKC is implicated in the signaling for proinflammatory responses of phagocytic cells such as generation of Obardot 2, actin assembly, and cell adherence. PKC is a family of structurally related isotypes that have different cofactor and substrate specificities (9, 10). It has therefore been suggested that different isotypes of PKC transduce different signals, although there is little evidence to date to indicate specific functions for each isotype of PKC.

Multiple isotypes of PKC were demonstrated in dHL60 cells including alpha -, beta I-, beta II-, delta -, and zeta -PKC, in agreement with other studies (15); the expression of these PKC isotypes is similar to the PKC isotypes observed in neutrophils (3, 14). In addition, the cofactors required for activation of PKC, calcium, DG and PIP3, are elevated in ligand-activated phagocytic cells, indicating a potential role for these PKC isotypes in activating responses such as Obardot 2 generation and adherence (37-40).

A role for beta -PKC in ligand-initiated responses was probed by selective depletion of the beta -PKC isotypes. Selective depletion by antisense was used since difficulty in distinguishing primary and secondary effects may be seen in overexpression studies either of the wild-type isotype or of a dominant negative mutant (41). Selective depletion of beta -PKC but not depletion of alpha -, delta -, or zeta -PKC was achieved using an antisense oligonucleotide designed against the translocation start site of beta -PKC. This oligonucleotide depleted both beta I-PKC and beta II-PKC, which are derived by alternate splicing and only differ at the 3' terminus. Depletion of beta -PKC by 45-60% was associated with decreased Obardot 2 generation triggered by PMA, fMet-Leu-Phe, or immune complexes. The extent of inhibition of Obardot 2 generation in beta -PKC-depleted cells was ligand dependent; the greatest inhibition was observed in fMet-Leu-Phe-activated cells and the smallest inhibition in PMA-activated cells. The greater degree of inhibition of Obardot 2 generation observed in response to fMet-Leu-Phe and immune complexes, as compared with PMA, may reflect differences in signaling initiated by these ligands. fMet-Leu-Phe may use beta -PKC at more than one step in the signaling pathway. There is a noteworthy difference in the kinetics of Obardot 2 generation triggered by PMA, which is continuous, as compared with the fMet-Leu-Phe-induced response, which ceases after approximately 3 min (1, 17). In addition, continuous receptor occupancy is required to maintain fMet-Leu-Phe-induced Obardot 2 generation (42). Thus, a role for beta -PKC might be involved in maintaining fMet-Leu-Phe-induced Obardot 2 generation. Finally, PMA is promiscuous and might recruit other PKC isotypes, whereas fMet-Leu-Phe may be constrained to recruit only beta -PKC for a key step in activation of the NADPH oxidase.

The inhibitory effect of beta -PKC depletion on Obardot 2 generation was functionally selective. The simultaneously elicited release of the azurophil granule markers, beta -glucuronidase and elastase (results not shown), from fMet-Leu-Phe-activated cells was not decreased in beta -PKC-depleted cells. This finding is concordant with previous findings that activators of PKC, such as PMA, do not trigger azurophil degranulation and that the kinase inhibitor staurosporine does not inhibit azurophil degranulation (17). These findings also demonstrate that beta -PKC depletion did not have a nonspecific effect on signaling for cell activation.

dHL60 cells adhere to fibronectin by a beta 1 integrin (36); adherence of dHL60 cells to a fibronectin-coated surface was triggered by PMA and fMet-Leu-Phe. Depletion of beta -PKC in dHL60 cells did not inhibit either PMA or fMet-Leu-Phe-induced adherence to fibronectin. Thus, signaling for adherence must use other isotypes of PKC such as alpha - or delta -PKC that, like beta -PKC, are also activated by PMA.

Identifying key substrate(s) is important in defining a role for beta -PKC in signal transduction. Addition of fMet-Leu-Phe to dHL60 cells triggered phosphorylation of numerous proteins. In beta -PKC-depleted cells, phosphorylation of a subset of proteins was reduced in response to fMLP, indicating a selective effect of beta -PKC depletion on ligand-induced phosphorylation. Phosphorylation of a cytosolic component of the NADPH oxidase, p47phox, and translocation and binding of p47phox to cytochrome b558 are essential steps in ligand-initiated activation of the NADPH oxidase. Indeed, depletion of beta -PKC reduced the fMet-Leu-Phe-induced phosphorylation of a 47-kDa band and phosphorylation of immunoprecipitated p47phox. However, the level of p47phox, which is a differentiation marker in HL60 cells, was not altered by depletion of beta -PKC. Thus, phosphorylation of p47phox is triggered by beta -PKC in activated dHL60 cells.

Phosphorylation of p47phox is required for a conformational change in p47phox, which releases binding of p47phox to itself and to p40phox (43), and allows translocation and binding of p47phox to membrane-associated cytochrome b558 (43-46). In the present study, fMet-Leu-Phe and PMA triggered phosphorylation and translocation of p47phox from the cytosol to the membrane in dHL60 cells. In beta -PKC-depleted dHL60 cells, the ligand-induced translocation of p47phox to the membrane was reduced, concordant with a role for beta -PKC in the phosphorylation and translocation of p47phox to the membrane-associated cytochrome b558 and activation of the NADPH oxidase. Several serines in the C terminus of p47phox, including Ser-303, Ser-304, and Ser-379, are consensus sequences for phosphorylation by PKC (47), and we have demonstrated that in vitro beta -PKC phosphorylates p47phox (3). The importance of a role for phosphorylation of p47phox by PKC for assembly of an active NADPH oxidase was demonstrated in a neutrophil cell-free system (4). Phosphorylation of Ser-379 was essential for translocation of p47phox to the membrane and activation of the NADPH oxidase, whereas a double mutatio